LMEDD (LataMed AI) Stock Based Compensation: $0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMEDD LataMed AI Corp LMEDD
26 GF Score
Price $1.36
! 3 Warning Signs
View Full Analysis

What is LataMed AI Stock Based Compensation?

LataMed AI LMEDD +10.57% 26 Stock Based Compensation is $0.00 Mil as of Mar. 2026. GuruFocus rates LMEDD with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

LataMed AI's Stock Based Compensation for the three months ended in Mar. 2026 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

LataMed AI Stock Based Compensation Related Terms

LataMed AI Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for LataMed AI's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LataMed AI Stock Based Compensation Chart

LataMed AI Annual Data
Trend Dec23 Dec24 Dec25
Stock Based Compensation
0.00 0.00 0.00

LataMed AI Quarterly Data
Sep09 Sep10 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LMEDD
26GF Score
LataMed AI Corp LMEDD
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LataMed AI Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
LataMed AI (LMEDD) has a Stock Based Compensation of $0.00 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for LataMed AI and its competitors.
Is LataMed AI's Stock Based Compensation too high?
LataMed AI's current Stock Based Compensation is $0.00 Mil. Overall, LataMed AI has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's Stock Based Compensation compare to KLTR and BZAI?
LataMed AI's Stock Based Compensation of $0.00 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Software company?
A good Stock Based Compensation depends on the Software industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for LataMed AI and its competitors. LataMed AI's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMEDD) has a current Stock Based Compensation of $0.00 Mil. The current Stock Based Compensation is $0.00 Mil. LataMed AI's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For LataMed AI (LMEDD), the current Stock Based Compensation is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LataMed AI Business Description

Address Av. Romulo Gallegos con Av. Las Palmas, Edif. Torre Gerencial Los Andes, Caracas, VEN, 1071
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
26GF Score

Get the complete analysis for LMEDD

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.36
Price